Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci (2008) 3.90

The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16

Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci (2009) 2.85

Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci (2008) 2.57

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A (1999) 2.16

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15

Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am J Pathol (2007) 1.77

Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J (2009) 1.73

Mechanisms underlying the rapid peroxisome proliferator-activated receptor-γ-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci (2012) 1.71

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am J Pathol (2004) 1.56

Nuclear receptors as therapeutic targets for Alzheimer's disease. Expert Opin Ther Targets (2011) 1.46

Cell division in the CNS: protective response or lethal event in post-mitotic neurons? Biochim Biophys Acta (2006) 1.41

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease. FASEB J (2009) 1.39

Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets (2010) 1.37

Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc Natl Acad Sci U S A (2005) 1.35

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol (2001) 1.34

Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci (2008) 1.30

Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol (2008) 1.23

Convergence of amyloid-beta and tau pathologies on mitochondria in vivo. Mol Neurobiol (2010) 1.16

Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease. J Neuroinflammation (2005) 1.16

Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Glia (2010) 1.15

Microglia in Alzheimer's disease and transgenic models. How close the fit? Am J Pathol (1999) 1.09

Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Hum Mol Genet (2009) 1.01

Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J Alzheimers Dis (2011) 1.01

Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies. Front Neurol (2013) 1.00

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET. Neurobiol Aging (2008) 1.00

Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease. J Neuroinflammation (2012) 0.98

Effects of fatty acid unsaturation numbers on membrane fluidity and α-secretase-dependent amyloid precursor protein processing. Neurochem Int (2010) 0.97

Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS One (2013) 0.96

Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease. Cell Death Dis (2010) 0.96

Imaging of microglia in patients with neurodegenerative disorders. Front Pharmacol (2012) 0.96

Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes. ASN Neuro (2010) 0.95

Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis. Am J Pathol (2008) 0.95

Modulation of adult-born neurons in the inflamed hippocampus. Front Cell Neurosci (2013) 0.94

Modes of Aβ toxicity in Alzheimer's disease. Cell Mol Life Sci (2011) 0.94

In vivo calcium imaging of the aging and diseased brain. Eur J Nucl Med Mol Imaging (2008) 0.93

Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. Future Neurol (2012) 0.93

Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging (2011) 0.91

APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). Neurosci Biobehav Rev (2012) 0.89

Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease. Am J Pathol (2000) 0.89

A limited role for microglia in antibody mediated plaque clearance in APP mice. Neurobiol Dis (2007) 0.89

Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions. Curr Pharm Des (2012) 0.88

Independent effects of intra- and extracellular Abeta on learning-related gene expression. Am J Pathol (2009) 0.87

CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease. PLoS One (2013) 0.87

The amyloid beta ion channel hypothesis of Alzheimer's disease. Neuropsychiatr Dis Treat (2007) 0.86

Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis. US Neurol (2010) 0.86

Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. J Neuroinflammation (2014) 0.85

Neurologic and motor dysfunctions in APP transgenic mice. Rev Neurosci (2012) 0.85

Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J Biol Chem (2012) 0.85

An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr Dis Treat (2008) 0.85

Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity. J Lipid Res (2009) 0.85

Persistence of Aβ seeds in APP null mouse brain. Nat Neurosci (2015) 0.85

Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl) (2016) 0.84

A Peephole into the Brain: Neuropathological Features of Alzheimer's Disease Revealed by in vivo Two-Photon Imaging. Front Psychiatry (2012) 0.84

Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex. PLoS One (2011) 0.84

Amyloid deposition and advanced age fails to induce Alzheimer's type progression in a double knock-in mouse model. Aging Dis (2011) 0.82

Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis. J Neurochem (2009) 0.82

Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease. Eur J Microbiol Immunol (Bp) (2013) 0.81

Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathol (2015) 0.81

Targeting S100B in Cerebral Ischemia and in Alzheimer's Disease. Cardiovasc Psychiatry Neurol (2010) 0.81

Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Int J Clin Exp Pathol (2012) 0.81

Young microglia restore amyloid plaque clearance of aged microglia. EMBO J (2016) 0.80

Glimepiride reduces CD14 expression and cytokine secretion from macrophages. J Neuroinflammation (2014) 0.79

Aging and the neurovascular unit. Ann N Y Acad Sci (2012) 0.79

Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI. J Cereb Blood Flow Metab (2015) 0.76

Alzheimer's disease, brain immune privilege and memory: a hypothesis. J Neural Transm (Vienna) (2006) 0.76

Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis. PLoS One (2015) 0.76

Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. Acta Neuropathol Commun (2016) 0.76

Correlated inflammatory responses and neurodegeneration in peptide-injected animal models of Alzheimer's disease. Biomed Res Int (2014) 0.76

Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40. Brain Inj (2016) 0.75

Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res (2016) 0.75

Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β. BMC Neurol (2016) 0.75

Plasma Exosomes Spread and Cluster Around β-Amyloid Plaques in an Animal Model of Alzheimer's Disease. Front Aging Neurosci (2017) 0.75

Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer's disease mouse models. Sci Rep (2016) 0.75

Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes. Int J Alzheimers Dis (2011) 0.75

Lessons Learned about Neurodegeneration from Microglia and Monocyte Depletion Studies. Front Aging Neurosci (2017) 0.75

Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice. Intravital (2013) 0.75

Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66

Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci (1997) 4.57

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42

ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA. Am J Pathol (1964) 4.39

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol (1997) 4.29

Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature (1995) 4.18

Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06

Alzheimer's disease: genotypes, phenotypes, and treatments. Science (1997) 3.72

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron (1996) 3.14

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev (1995) 3.05

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91

Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85

Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci (1996) 2.69

Neuron loss in APP transgenic mice. Nature (1998) 2.38

Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature (1997) 2.26

Brain microglia constitutively express beta-2 integrins. J Neuroimmunol (1990) 2.09

Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci (1997) 1.87

Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (1992) 1.71

Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion. J Neurosci (1991) 1.70

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci (1996) 1.59

Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging (1997) 1.56

Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease. Neurobiol Aging (1998) 1.56

Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett (1990) 1.51

Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41

Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging (1999) 1.38

The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol (1990) 1.31

Role of microglia in senile plaque formation. Neurobiol Aging (1996) 1.23

Phagocytosis of beta/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol (1991) 1.22

Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol (1998) 1.17

Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy. J Neurosci Res (1992) 1.09

Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia (1993) 0.99

Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience (1994) 0.99

Beta-amyloid peptide secretion by a microglial cell line is induced by beta-amyloid-(25-35) and lipopolysaccharide. J Biol Chem (1996) 0.98

Ultrastructure of the cells forming amyloid fibers in Alzheimer disease and scrapie. Am J Med Genet Suppl (1990) 0.98

Microglial response to transient focal cerebral ischemia: an immunocytochemical study on the rat cerebral cortex using anti-phosphotyrosine antibody. J Cereb Blood Flow Metab (1994) 0.96

Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study. J Neuropathol Exp Neurol (1993) 0.89

Phosphotyrosine antibodies specifically label ameboid microglia in vitro and ramified microglia in vivo. Glia (1989) 0.88

Alzheimer's disease: coated vesicles, coated pits and the amyloid-related cell. Proc R Soc Lond B Biol Sci (1988) 0.85

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66

RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell (1993) 5.62

Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science (1999) 4.56

Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science (2002) 3.93

A family of AMPA-selective glutamate receptors. Science (1990) 3.85

Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 3.22

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84

Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature (1998) 2.56

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49

Neuron loss in APP transgenic mice. Nature (1998) 2.38

Different structural systems of the nucleus are targets for SV40 large T antigen. Cell (1983) 2.18

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A (1999) 2.16

Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res (2002) 2.08

Preparation of nuclear matrices from cultured cells: subfractionation of nuclei in situ. J Cell Biol (1984) 2.07

Neuropathology in mice expressing human alpha-synuclein. J Neurosci (2000) 2.06

Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol (2006) 1.87

Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci (2000) 1.84

Alzheimer's paired helical filaments share epitopes with neurofilament side arms. EMBO J (1986) 1.81

Comparative evaluation of synaptophysin-based methods for quantification of synapses. J Neurocytol (1996) 1.80

The dopamine D2 receptor: two molecular forms generated by alternative splicing. EMBO J (1989) 1.79

Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77

The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J (2003) 1.75

Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci U S A (1998) 1.68

Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res (1983) 1.60

CONTROL OF ETHANOL DEHYDROGENASE LEVELS IN AEROBACTER AEROGENES. J Bacteriol (1961) 1.56

[Bridging peripheral nerve defects by means of nerve conduits]. Chirurg (2007) 1.52

Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci (2001) 1.51

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging (2002) 1.50

Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains. J Biol Chem (2001) 1.49

Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health (2001) 1.48

A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J Neurochem (1992) 1.42

Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 1.41

Dystroglycan in the cerebellum is a laminin alpha 2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci (1996) 1.40

Stereological analysis of astrocyte and microglia in aging mouse hippocampus. Neurobiol Aging (1999) 1.38

Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunocytochemical and electron-microscopic study. Acta Neuropathol (1982) 1.38

Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis (1997) 1.37

Neonatal intracranial hemorrhage in premature infants. Pediatrics (1975) 1.36

Intermediate filament systems are collapsed onto the nuclear surface after isolation of nuclei from tissue culture cells. Exp Cell Res (1982) 1.36

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol (2001) 1.34

Stereological estimation of total microglia number in mouse hippocampus. J Neurosci Methods (1998) 1.33

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev Neurol (Paris) (2013) 1.33

Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice. Neurobiol Aging (1999) 1.30

Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (1989) 1.27

Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J Neurol Neurosurg Psychiatry (1986) 1.27

Can an endocytoscope system (ECS) predict histology in neoplastic lesions? Endoscopy (2007) 1.25

Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. J Neurosci (1999) 1.25

REVIEW: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol (1999) 1.23

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res (1986) 1.22

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience (1987) 1.22

Dyke Davidoff Masson syndrome with crossed cerebellar atrophy: an old disease in a new millenium. Neuropathol Appl Neurobiol (2001) 1.20

Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res (2005) 1.20

Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J Neurosci (1997) 1.20

Electrophoretic separation of betaA4 peptides (1-40) and (1-42). Anal Biochem (1996) 1.20

Distinct Streptococcus thermophilus bacteriophages share an extremely conserved DNA fragment. Virology (1994) 1.19

Ankyrin is fatty acid acylated in erythrocytes. Proc Natl Acad Sci U S A (1986) 1.19

beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin. Proc Natl Acad Sci U S A (1993) 1.19

3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging (2001) 1.18

(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther (1999) 1.17

Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (1983) 1.16

Identification of a 110-kDa nonintegrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide. Arch Biochem Biophys (1991) 1.16

Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther (2002) 1.14

The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Mol Med (2001) 1.14

Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem (1999) 1.13

Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model. Ann N Y Acad Sci (2000) 1.12

New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (1989) 1.12

Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol Aging (1996) 1.12

Biotinidase deficiency: a cause of subacute necrotizing encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome. Pediatr Res (1989) 1.12

The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities. J Biol Chem (1996) 1.10

Trace elements in stream bed sediments from agricultural catchments (Gascogne region, S-W France): where do they come from? Sci Total Environ (2009) 1.09

Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience (1989) 1.08

No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice. Neuroscience (1999) 1.08

Cerebellar ganglioglioma in a child. J Neuropathol Exp Neurol (1979) 1.08

[Senile subcortical neurofibrillary degeneration with the presence of twisted tubules and straight filaments. Atypical form of progressive supranuclear paralysis]. Rev Neurol (Paris) (1978) 1.07

Distinct role of protein phosphatase 2A subunit Calpha in the regulation of E-cadherin and beta-catenin during development. Mech Dev (2000) 1.07

The distribution of glycine receptors in the human brain. A light microscopic autoradiographic study using [3H]strychnine. Neuroscience (1986) 1.07

Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J Neurochem (2003) 1.06

Control of magnetohydrodynamic stability by phase space engineering of energetic ions in tokamak plasmas. Nat Commun (2012) 1.06

A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1. J Neurosci Res (1995) 1.06